Utility of PCD Diagnostics to Improve Clinical Care
ConditionPrimary Ciliary Dyskinesia
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age1+
SponsorVanderbilt University Medical Center
About this trial
This is a study evaluating the utility of current Primary Ciliary Dyskinesia (PCD) diagnostic tests, including nasal nitric oxide testing.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Referred to center for PCD diagnosis considerations
Ability to perform study procedures
Age greater than 2 years of age
Disqualifiers
Age less than 2 years of age Inability to perform informed consent
Trial design
Design model
Single group
Treatments tested in this trial
nNO testing
Other interventionCollection of already performed clinical data and nNO testing
Treatment groups
200 Participants
are divided into 1 treatment groupGroup A: Nasal Nitric Oxide testing and collection of clinical dataOther 1 intervention
Trial outcomes
Primary outcomes
1
frequency of nNO tests performed
number of tests
Time frame
3 years2
Frequency of genetic tests performed
number of tests
Time frame
3 yearsSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov